Screening for Sexually Transmitted Infection Pathogens in Semen Samples

The transmission of sexually transmitted infection (STI) pathogens from an infected donor to the recipient of a semen donation in assisted conception may result not only in acute infection but also in long-term reproductive complications or adverse outcomes of pregnancy, including infection of the o...

Full description

Saved in:
Bibliographic Details
Main Authors: RW Peeling, J Embree
Format: Article
Language:English
Published: Wiley 2005-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2005/958374
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849694068202799104
author RW Peeling
J Embree
author_facet RW Peeling
J Embree
author_sort RW Peeling
collection DOAJ
description The transmission of sexually transmitted infection (STI) pathogens from an infected donor to the recipient of a semen donation in assisted conception may result not only in acute infection but also in long-term reproductive complications or adverse outcomes of pregnancy, including infection of the offspring. Screening for bacterial STI pathogens, Chlamydia trachomatis and Neisseria gonorrhoeae is strongly recommended because these pathogens can cause serious reproductive complications in the recipients of semen donations and infection in their offspring. Screening for these pathogens should be performed using the most sensitive methods, such as nucleic acid amplified tests. False-negative results due to inhibitory substances in the semen sample should be monitored using amplification controls. Where specimen transport is not a problem and culture facilities are available, N gonorrhoeae can also be detected by culture. Laboratories performing screening should subscribe to proficiency programs and have strict quality controls. Although Trichomonas vaginalis, group B streptococcus and genital mycoplasmas have been associated with adverse outcomes of pregnancy, the frequent finding of these organisms in healthy individuals brings into question the validity of mandatory inclusion of these organisms in the screening panel. Although viral STI pathogens and Treponema pallidum -- the causative agent of syphilis -- may be detected in semen, their presence may be more sensitively detected through antibody testing of the donor. Screening donors for HIV, hepatitis B and syphilis by serology is uniformly recommended in all of the guidelines, but the value of screening either donors or semen samples for cytomegalovirus, herpes simplex viruses and human papilloma viruses is less clear.
format Article
id doaj-art-4bdec34230744a058559f1fa1b70bcac
institution DOAJ
issn 1712-9532
language English
publishDate 2005-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-4bdec34230744a058559f1fa1b70bcac2025-08-20T03:20:13ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322005-01-01162737610.1155/2005/958374Screening for Sexually Transmitted Infection Pathogens in Semen SamplesRW Peeling0J Embree1World Health Organization, Geneva, SwitzerlandDepartment of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, CanadaThe transmission of sexually transmitted infection (STI) pathogens from an infected donor to the recipient of a semen donation in assisted conception may result not only in acute infection but also in long-term reproductive complications or adverse outcomes of pregnancy, including infection of the offspring. Screening for bacterial STI pathogens, Chlamydia trachomatis and Neisseria gonorrhoeae is strongly recommended because these pathogens can cause serious reproductive complications in the recipients of semen donations and infection in their offspring. Screening for these pathogens should be performed using the most sensitive methods, such as nucleic acid amplified tests. False-negative results due to inhibitory substances in the semen sample should be monitored using amplification controls. Where specimen transport is not a problem and culture facilities are available, N gonorrhoeae can also be detected by culture. Laboratories performing screening should subscribe to proficiency programs and have strict quality controls. Although Trichomonas vaginalis, group B streptococcus and genital mycoplasmas have been associated with adverse outcomes of pregnancy, the frequent finding of these organisms in healthy individuals brings into question the validity of mandatory inclusion of these organisms in the screening panel. Although viral STI pathogens and Treponema pallidum -- the causative agent of syphilis -- may be detected in semen, their presence may be more sensitively detected through antibody testing of the donor. Screening donors for HIV, hepatitis B and syphilis by serology is uniformly recommended in all of the guidelines, but the value of screening either donors or semen samples for cytomegalovirus, herpes simplex viruses and human papilloma viruses is less clear.http://dx.doi.org/10.1155/2005/958374
spellingShingle RW Peeling
J Embree
Screening for Sexually Transmitted Infection Pathogens in Semen Samples
Canadian Journal of Infectious Diseases and Medical Microbiology
title Screening for Sexually Transmitted Infection Pathogens in Semen Samples
title_full Screening for Sexually Transmitted Infection Pathogens in Semen Samples
title_fullStr Screening for Sexually Transmitted Infection Pathogens in Semen Samples
title_full_unstemmed Screening for Sexually Transmitted Infection Pathogens in Semen Samples
title_short Screening for Sexually Transmitted Infection Pathogens in Semen Samples
title_sort screening for sexually transmitted infection pathogens in semen samples
url http://dx.doi.org/10.1155/2005/958374
work_keys_str_mv AT rwpeeling screeningforsexuallytransmittedinfectionpathogensinsemensamples
AT jembree screeningforsexuallytransmittedinfectionpathogensinsemensamples